SEC Tracker
Get the app

NeuroPace NPCE

OrbiMed Private Investments VI (Shareholder) plans to sell 288,100 NPCE shares, about $2.6M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Oct 2, 2023
  2. Broker: JP Morgan Chase & Co.
  3. Shares acquired by: IPO

All of OrbiMed Private Investments VI's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 7,614 shares at $9.08 on Oct 2, 2023 · Form 4
  • Sold 700 shares at $9.02 on Oct 3, 2023 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when NeuroPace files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. ClearPoint Neuro CLPT public float $328M, Jun 30, 2025
  2. Outset Medical OM public float $335M, Jun 30, 2025
  3. SS Innovations International SSII public float $270M, Jun 30, 2025
  4. EBR Systems EBRCZ public float $351M, Jun 30, 2025
  5. Treace Medical Concepts TMCI public float $266M, Jun 30, 2025